FDA Import Refusal 8NP-0055987-6/11/1 — Eli Lilly Italia SPA
The FDA refused shipment 8NP-0055987-6/11/1 from Eli Lilly Italia SPA (Italy) on Feb 9, 2021. The refused product falls under Drugs and Biologics — OLAPARIB (ANTI-NEOPLASTIC - PART II). Cited charges: 118,2280,71,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 9, 2021
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 62ZCL37 OLAPARIB (ANTI-NEOPLASTIC - PART II)
- Charges
- 118,2280,71,75